(Q78099483)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437655%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

title

Immunomodulatory effects of IFNbeta-1b on the mRNA-expression of TGFbeta-1 and TNFalpha in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437655%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

author name string

L M Ossege

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437655%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

E Sindern

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437655%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

B Voss

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437655%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

J P Malin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437655%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437655%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437655%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437655%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437655%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

page(s)

39-46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437655%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

A membrane-filter technique for the detection of complementary DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Influence of serum on zinc, toxic shock syndrome toxin-1, and lipopolysaccharide-induced production of IFN-gamma and IL-1 beta by human mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch?

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Transforming growth factor beta: its mechanism of action and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Immunological aspects of demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Multiple sclerosis (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Electrophoresis in agarose and acrylamide gels

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Tumor necrosis factor (TNF).

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Detection of transforming growth factor beta 1 mRNA in cerebrospinal fluid cells of patients with meningitis by non-radioactive in situ hybridization.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta1 and its receptor type II

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Recombinant Interferon-β blocks proliferation but enhances interleukin-10 secretion by activated human T-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 in cultured fetal human astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Suppression of immune cell function in vitro by recombinant human transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

Deactivation of macrophages by transforming growth factor-β

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900038-7

7 January 2021

10.1016/S0162-3109(99)00038-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10437655%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference